Tag: Combinat
HOOKIPA Pharma Announces Positive Preliminary Phase 2 Data on HB-200 in...
HB-200 in combination with pembrolizumab doubled the objective response rate of 1st-line pembrolizumab for patients with recurrent/metastatic head and neck cancerHOOKIPA is preparing...